長江生命科技簡介 長江生命科技集團有限公司於香港聯合交易所有限公司 上市 本著提升人類生活質素之使命 長江生命科技從事 健康及農業相關產品的研發 商品化 推廣及銷售業務 開發之產品範疇包括人類健康及環境生態兩方面 部分 發明已獲得美國專利及商標註冊處頒發專利 長江生命 科技為長江和記實業集團成員

Similar documents

CK Life Sciences Int'l., (Holdings) Inc.

i

00C AR.indb


Kingwell_C_MT Cir.indb

untitled






企 業 簡 介 公 司 資 料

untitled

untitled





i




目錄

公 司 簡 介

港燈電力投資 年年報

(1) (2) (3)

untitled


目 錄 頁 次 釋 義 董 事 會 函 件 言


untitled

Kingsoft Cloud Chi.indb

GEM GEM GEM GEM GEM GEM GEM GEM GEM

2018 Hope Education Group Co., Ltd

untitled




00C AR.indb


目 錄 頁 碼 定 義... I 董 事 會 函 件... 1 附 錄 I 財 務 信 息... I-1 附 錄 II 一 般 信 息... II-1 1



2013 Cricket Square, Hutchins Drive P.O. Box 2681 Grand Cayman KY Cayman Islands Royal Bank of Canada Trust Company (Cayman) Limited 4t

607_AR15_cove_final




C Ann.indd

和寶國際控股有限公司

c01083.pdf


書冊1.indb

i

(I)... 2 (II)... 4 (III)... 6 (IV) (V) (VI) (VII) (VIII)

/ 2015 CONSOLIDATED STATEMENT OF PROFIT For the six months ended 30 December


untitled

Transcription:

0775 提 升 美 好 生 活 農 業 相 關 保 健 產 品 醫 藥 項 目

長江生命科技簡介 長江生命科技集團有限公司於香港聯合交易所有限公司 上市 本著提升人類生活質素之使命 長江生命科技從事 健康及農業相關產品的研發 商品化 推廣及銷售業務 開發之產品範疇包括人類健康及環境生態兩方面 部分 發明已獲得美國專利及商標註冊處頒發專利 長江生命 科技為長江和記實業集團成員

2 6 農 業 相 關 業 務 保 健 產 品 業 務 醫 藥 項 目 24 25 26 28 38 49 51 52 53 55 56 58 118 123 124 125 161 166

2

0.009 0.008 3

McWilliam s Accensi Pty Ltd Accensi Accensi Santé Naturelle A.G. Ltée Vitaquest International Holdings LLC Vitaquest Vitaquest Lipa Pharmaceuticals Limited Lipa Lipa Lipa Complementary Medicines Australia 4

1. Polynoma LLC Polynoma LLC FDA 2. WEX Pharma WEX Pharmaceuticals Inc. Tetrodotoxin TTX 3. WEX PharmaTTX WEX PharmaTTXFDA 5

Accensi Amgrow Cheetham Salt McWilliam s

8

Belvino Challenger Wine Trust CWT CWT Belvino Investments Trust BelvinoBelvino McWilliam s Mud House Northbank Millennium Margaret River Qualco West McWilliam s Griffith Hanwood Coonawarra Station & Kirkgate McWilliam s McWilliam s Wines Group Mud House Marlborough Woolshed Waipara Mound Home Deans Otago Claim Northbank Millennium Marlborough Margaret RiverOld Land Rowe RoadLionels Qualco West Riverland 9

Cheetham Salt Cheetham Salt Limited Cheetham Cheetham Cheetham Cheetham Cheetham Cheetham Cheetham Cheetham PVC Cheetham 10

Cheetham Salt Limited Dominion Salt Pure Dried Vacuum PDV ISO 22000:2005 22000 Dominion Salt ISO 22000 PDV Dominion Salt 11

Amgrow Amgrow Amgrow Pty Ltd Amgrow 12

Darryn Lyons Corangamite Sarah HendersonAccensi Amgrow P e a t y Trading Group PeatyPeaty Amgrow Amgrow Accensi Accensi Pty Ltd Accensi Accensi Accensi Accensi Accensi 13

Lipa Vitaquest Santé Naturelle A.G.

Santé Naturelle A.G. Santé Naturelle A.G. Ltée Santé Naturelle Adrien Gagnon Santé Naturelle Adrien Gagnon Santé Naturelle Santé Naturelle Santé Naturelle Santé Naturelle 16

Vitaquest Vitaquest Vitaquest International Holdings LLC Vitaquest Vitaquest Vitaquest Vitaquest Vitaquest 17

Lipa Lipa Pharmaceuticals Limited Lipa Lipa Lipa Lipa Lipa Lipa LipaComplementary Medicines Australia LipaComplementary Medicines Australia 18

19

Polynoma WEX Pharmaceuticals

Polynoma Polynoma Polynoma LLC Polynoma Polynoma Polynoma FDA 22

WEX Pharmaceuticals WEX Pharmaceuticals Inc. WEX Pharma WEX Pharma Tetrodotoxin TTX TTX WEX Pharma TTX WEX Pharma FDA TTX WEX Pharma 23

24

2011 2012 2013 2014 2015 3,511,563 4,545,022 4,970,927 4,954,043 4,919,309 125,826 176,331 229,008 263,558 284,912 2011 2012 2013 2014 2015 6,624,522 6,870,090 7,332,998 7,297,108 6,677,617 2,185,713 2,429,873 2,886,780 3,000,242 2,918,519 (922,279) (1,178,104) (2,215,741) (1,142,482) (2,444,571) (2,255,398) (2,398,161) (2,803,742) (4,279,899) (2,812,981) 5,632,558 5,723,698 5,200,295 4,874,969 4,338,584 5,368,759 5,463,812 4,976,937 4,662,648 4,178,595 263,799 259,886 223,358 212,321 159,989 5,632,558 5,723,698 5,200,295 4,874,969 4,338,584 25

2,834.91,356.0 1,113.5585.9 104.9 9,596.1 840.8 223.1 3.1 45.0 4,338.6 0.45 43.58% / / 183.1 60.6 / 26

1,745 1,675 70 929.9 2% 27

51 / Li Ka Shing (Canada) Foundation XV XV 2 3 69 XV 28

63 ARA Asset Management Limited TOM XV 2 3 60 Johnson & Johnson 71 22 TULLOCH, Peter Peace 72 Victoria Power Networks Pty Ltd SA Power Networks Australian Gas Networks Limited Tulloch Powercor Australia Limited CitiPower Pty Tulloch XV Tulloch 30 Tulloch 29

74 Amara Holdings Inc. Amara Li Ka Shing (Canada) Foundation LKS Canada Foundation Amara LKS Canada Foundation XV Pension Fund Society Shoppers Drug Mart Corporation Telesystems International Wireless (TIW) Inc. Fletcher Challenge Canada Ltd. Clarica Life Insurance Company Air Canada Innovation Saskatchewan (IS) Saskatchewan-Asia Advisory Council 75 ARA Asset Management Limited XV RCA Ltd RCA Ltd Associated Electrical Industries 30

66 China Properties Group Limited / XV 31

44 20 55 20 50 Richard Ivey 20 Midland Walwyn Capital Bankers Trust 61 30 57 Richard Ivey 25 General Electric Applied Materials Rockwell Automation WesTrac China 32

56 Glaxo GlaxoSmithKline Schering-Plough Merck 30 60 / 30 Celgene Corporation Technical Resources Inc. Sybron AgraQuest Inc. 47 20 56 30 Peak International Pacific Dunlop (Australia) 51 American Society for Quality / 25 33

49 25 Pfizer Global R&D Pfizer 55 The University of Hawaii at Manoa Bozell Tong Barnes PR 46 The Institute of Internal Auditors 20 55 34

BARBER, Paul 52 Accensi Pty Ltd. Harvard Business School Elders Ltd. Incitec Pivot Ltd. AWB Landmark Hifert Australia Australian Wool Handlers B&W Rural PlantTech Seeds BARRINGTON-CASE, Angus 41 Regenal Investments Pty Ltd. University of South Australia Australian Property Institute Certified Practicing Property Valuer Specialist Water Valuer Royal Institute of Chartered Surveyors Barrington-Case Taylor Brooke McGees Property Colliers International FRANKEL, Keith 51 Vitaquest International LLC American University Vitaquest International Frankel Vitaquest Frankel Frankel GALLEN, Christopher 65 WEX Pharmaceuticals Inc. MD PhD Emory University Scripps Research Institute Gallen Quintiles Premier Research Worldwide Wyeth Pharmacia Neuromed WEX Pharmaceuticals Inc. Gallen SK Biopharmaceuticals Gallen 35

58 Australian Agribusiness (Holdings) Pty Ltd. Amgrow Accensi Australian Agribusiness (Holdings) Pty Ltd. MALLON, Patrick 55 Polynoma LLC Mallon Polynoma Mallon 500 OPACIC, Bob 60 Amgrow Pty Ltd. Opacic Amgrow Pty Ltd. Envirogreen Pty Ltd. Brambles CSR Ashland Inc. 20 PEJNOVIC, Dusko 56 Lipa Pharmaceuticals Ltd. Lipa Lipa Lipa Australian Institute of Management Complementary Medicines Australia Pejnovic 36

ROY, Daniel 45 Santé Naturelle Adrien Gagnon Ltd. Santé Naturelle Adrien Gagnon Ltd. Roy 15 SPEED, Andrew 42 Cheetham Salt Ltd. Cheetham Salt Cheetham Salt Speed Orica Ltd. 65 CK Life Sciences (North America) Inc. Vitaquest International LLC York University University of Wisconsin York University 18BMO Nesbitt Burns HSBC Deloitte 37

6 23 2 5 25 26 27 161 165 38

FDA 51 0.009 25 166 28 31 3.13 3.13 39

40

XV XV 7 8 352 2,250,000 2,835,759,715 2,838,009,715 29.52% 6,225,000 6,225,000 0.06% 2,250,000 2,250,000 0.02% 2,250,000 2,250,000 0.02% 2,250,000 2,250,000 0.02% Peter Peace Tulloch 1,050,000 1,050,000 0.01% 200,000 200,000 0.002% 2,835,759,715 XV XV 7 8 352 41

XV 2 3 336 Gold Rainbow Int l Limited 4,355,634,570 45.31% Gotak Limited 4,355,634,570 i 45.31% 4,355,634,570 ii 45.31% 4,355,634,570 iii 45.31% Trueway International Limited 2,119,318,286 22.05% 2,835,759,715 iv 29.50% 2,835,759,715 v 29.50% 42

Triluck Assets Limited 716,441,429 7.45% i. Gold Rainbow Int l Limited Gold Rainbow Gold Rainbow Gotak Limited Gotak Limited Gold Rainbow ii. Gotak Limited Gotak Limited iii. iv. Trueway International Limited Trueway Triluck Assets Limited Triluck 2,835,759,715 Trueway Triluck v. XV 2 3 336 (i) (ii) 43

* # (ii) (ii) (i) (ii) (i) (ii) (i) (ii) # (i) (ii) (ii) (i) (ii) (ii) TOM (ii) ^ (ii) (ii) ARA Asset Management Limited (ii) (i) * # ^ 44

Vitaquest International LLC Vitaquest Leknarf Associates, LLC Leknarf VQ I VQ II VQ I VQ II VQ (i) Vitaquest Leknarf VQ I (ii) Vitaquest Leknarf VQ II I 2% VQ 228,000 1,774,000 1,127,000 8,768,000 551,000 * 4,287,000 616,000 4,804,800 VQ II 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 493 749 764 779 795 811 827 844 860 878 895 150 Leknarf 271,708 2,119,000 1,340,387 10,455,000 0 *0 689,176 5,376,000 Leknarf Leknarf 14A.60(1) 14A * Vitaquest Leknarf Vitaquest Leknarf I VQ 45

(a) / (b) / 30% 50% / / II II II (a) 110,000,000 115,500,000 121,275,000 (b) 17,000,000 17,850,000 18,742,500 26,596,000 2,696,000 II 46

I II (i) (ii) (iii) 14A.56 3000 Assurance Engagements Other Than Audits or Reviews of Historical Financial Information 740 Auditor s Letter on Continuing Connected Transactions under the Hong Kong Listing Rules (i) (ii) (iii) ; 47

13.21 Ample Castle Limited Ample Ample 70,000,000 546,000,000 44.01% 144 147 C.3 48

51 124 2015 12 31 49

2015 12 31 2016 3 14 50

2015 12 31 2015 2014 7 4,919,309 4,954,043 (3,177,462) (3,213,721) 1,741,847 1,740,322 8 20,857 64,341 9 (491,719) (497,986) (23,027) (22,782) (38,681) (44,271) (811,167) (864,850) 10 (104,889) (109,566) 48,221 55,922 341,442 321,130 11 (72,778) (48,378) 12 268,664 272,752 284,912 263,558 (16,248) 9,194 268,664 272,752 13 2.96 2.74 2.96 2.74 51

2015 12 31 2015 2014 268,664 272,752 / (614,032) (414,346) / (62,802) 25,300 (24,236) (701,070) (389,046) (432,406) (116,294) (394,224) (110,860) (38,182) (5,434) (432,406) (116,294) 52

2015 12 31 2015 2014 15 991,434 1,141,481 16 479,927 549,113 17 1,129,781 1,136,213 18 3,535,281 3,785,560 19 303,174 336,159 20 194,723 314,815 30 43,297 33,767 6,677,617 7,297,108 21 25,041 54,540 22 3,338 5,207 8,734 4,916 23 923,382 971,149 24 1,117,273 985,230 25 840,751 979,200 2,918,519 3,000,242 26 (910,958) (946,291) 22 (2,707) (4,479) 27 (1,431,864) (128,629) 28 (425) (346) (98,617) (62,737) (2,444,571) (1,142,482) 473,948 1,857,760 7,151,565 9,154,868 53

2015 12 31 2015 2014 27 (1,403,000) (2,871,858) 28 (1,092) (847) 29 (1,356,000) (1,356,000) 30 (52,889) (51,194) (2,812,981) (4,279,899) 4,338,584 4,874,969 31 961,107 961,107 3,217,488 3,701,541 4,178,595 4,662,648 159,989 212,321 4,338,584 4,874,969 54

2015 12 31 2014 1 1 961,107 3,993,767 34,114 34,379 (390,892) 2,502 (182,045) 524,005 4,976,937 223,358 5,200,295 263,558 263,558 9,194 272,752 (399,718) (399,718) (14,628) (414,346) 25,300 25,300 25,300 / 25,300 (399,718) 263,558 (110,860) (5,434) (116,294) (136,879) (136,879) 10,519 (126,360) 30,212 30,212 728 728 (33,084) (32,356) (2,502) 2,502 2013 0.007 (67,278) (67,278) (67,278) (13,250) (13,250) 2015 1 1 961,107 3,926,489 59,414 34,379 (789,882) (318,924) 790,065 4,662,648 212,321 4,874,969 / 284,912 284,912 (16,248) 268,664 (592,098) (592,098) (21,934) (614,032) (62,802) (62,802) (62,802) (24,236) (24,236) (24,236) / (87,038) (592,098) 284,912 (394,224) (38,182) (432,406) (12,941) (12,941) 7,866 (5,075) 2014 0.008 (76,888) (76,888) (76,888) (22,016) (22,016) 2015 12 31 961,107 3,849,601 (27,624) 34,379 (1,381,980) (331,865) 1,074,977 4,178,595 159,989 4,338,584 55

2015 12 31 2015 2014 341,442 321,130 (48,221) (55,922) 104,889 109,566 88,510 92,032 (51,168) (32,225) (17,798) 1,869 931 (1,712) 12,361 5,697 7,006 / (491) 1,769 (368) (3,450) (7,655) 38,681 44,271 / 86,488 (91,765) 6,715 91,174 / 5,490 (3,356) 6,600 9,747 (18,481) 10,108 16,812 567,572 503,104 (31,301) (69,017) / (204,582) 27,227 / 12,578 (113,532) (40,560) (23,259) 303,707 324,523 (84,484) (210,725) (16,594) (138,326) (195,666) (140,861) (47,306) (5,603) 4,255 5,579 2,924 3,470 9,723 1,353 38 19,657 753 84,222 61,724 7,183 41,702 41,405 3,450 7,655 (130,471) (414,039) 56

2015 12 31 2015 2014 12,163 1,073,227 (97,280) (468,000) (981) (901) (105,238) (110,327) (5,075) (126,360) (17,734) (17,169) (76,888) (67,278) / (291,033) 283,192 / (117,797) 193,676 956,761 769,212 (18,562) (6,127) 25 820,402 956,761 57

1. 2. 1 1 16 1 38 16 1 41 27 1 9 3 14 2 15 3 10 28 4 10 1 12 28 11 1 2012-2014 1 1 2016 1 1 2 2016 1 1 3 2018 1 1 4 58

2. 9 2009 9 2010 2013 2014 39 9 9 9 39 39 9 39 9 59

2. 9 15 15 18 11 15 1 2 3 4 5 15 15 15 15 16 41 16 41 41 16 41 60

3. 2 17 2 36 (a) 61

3. (a) (i) (ii) 39 62

3. (b) 12 19 2 5 63

3. (b) 39 37 (c) / (d) 64

3. (e) / 6 2 / 3 % 20% 2.5% 12.5% 4% 50% 5% 50% 65

3. (e) (f) i. ii. 66

3. (f) iii. iv. v. 67

3. (f) vi. vii. (g) (f) / / 68

3. (g) / / (h) 5 69

3. (h) 39 36 36 39 70

3. (i) / / / / / / i. / / / / / 71

3. (i) i. / / / 39 ii. 72

3. (i) iii. iv. 73

3. (i) iv. v. vi. vii. 74

3. (i) viii. (j) (k) 75

3. (k) (l) 76

3. (l) (m) (n) 2002 11 7 2005 1 1 2 2005 1 1 2005 1 1 (o) 77

3. (o) 2005 1 1 2005 1 1 78

3. (p) 79

3. (p) (q) 4. 3 / 18 80

4. 2015 12 31 43,297,000 2014 33,767,000 (i) (ii) (iii) (iv) 6 5. 2015 12 31 43.58% 2014 40.93% 81

5. (a) 2015 12 31 24 (b) 82

5. (b) 2015 910,958 2,834,864 1,517 1,356,000 5,103,339 1 910,958 1,477,322 500 27,368 2,416,148 1 2 1,417,499 410 1,359,357 2,777,266 2 5 780 780 910,958 2,894,821 1,690 1,386,725 5,194,194 2014 946,291 3,000,487 1,193 1,356,000 5,303,971 1 946,291 199,811 398 27,560 1,174,060 1 2 1,518,687 349 27,560 1,546,596 2 5 1,416,727 542 1,359,380 2,776,649 946,291 3,135,225 1,289 1,414,500 5,497,305 2015 12 31 2014 12 31 83

5. (c) 20 21 22 25 27 29 2015 12 31 50 / 20,702,000 2014 21,497,000 / / 50 2015 12 31 4,140,464,000 2014 4,299,427,000 / 84

5. (d) (e) 20 21 / 5% / 1,252,000 20142,727,000 2,235,000 (20147,841,000/ 5% 85

6. (a) 2015 44,707 44,707 25,041 25,041 3,338 3,338 25,041 3,338 28,379 2,707 2,707 2014 156,815 156,815 54,540 54,540 5,207 5,207 54,540 5,207 59,747 4,479 4,479 86

6. (a) (b) 2015 991,434 991,434 479,927 479,927 104,039 104,039 306,891 306,891 104,039 306,891 410,930 238,894 238,894 2014 1,141,481 1,141,481 549,113 549,113 107,269 107,269 256,241 256,241 107,269 256,241 363,510 270,368 270,368 2015 12 31 2014 12 31 87

6. (b) 2015 12 31 2014 12 31 7.8% 13.25% (2014: 9.1% 13.25%) / / 3,920 82,136 (2014: 14,753 81,360 / / / / 5,320 5,880 (2014: 6,023 6,657 / / 11% 13% (2014: 11% 13%) / / / / 88

6. (b) 15 16 17 2015 2014 1 1 256,241 284,486 33,665 58,181 3,046 / (33) (214) (7,643) (6,828) (33,520) (24,249) 12 31 306,891 256,241 7. 2015 2014 2,098,857 2,216,803 2,810,296 2,730,524 10,156 6,716 4,919,309 4,954,043 89

8. 2015 2014 3,064 6,997 386 658 / (86,488) 91,765 (6,715) (91,174) 51,168 32,225 17,798 (1,869) (931) 9. 929.9 2014 908.2 438.2 2014 410.2 10. 2015 2014 77,277 82,311 27,559 27,179 53 76 104,889 109,566 90

11. 2015 2014 74,458 36,854 / 89 (806) 30 (1,769) 12,330 72,778 48,378 16.5% 2015 2014 341,442 321,130 16.5% 56,338 52,986 (7,956) (9,227) 61,419 44,771 (83,392) (83,463) 19,204 26,781 / 89 (806) (3,110) (6,333) 30,500 23,204 (314) 465 72,778 48,378 91

12. 2015 2014 12,023 14,672 88,308 91,611 202 421 88,510 92,032 (65,483) (69,250) 23,027 22,782 183,125 190,823 34,836 24,917 5,490 6,708 10,896 10,108 16,812 57,916 57,579 5,697 7,006 1,769 12,361 1,142 149,267 163,567 4,474 4,744 3,710 3,356 108 1,149 18,481 491 368 1,712 1,972 1,972 92

13. 2015 2014 284,912 263,558 9,611,073,000 9,611,073,000 2015 2014 12 31 14. 2015 12 31 0.009 2014 0.008 86,500,000 2014 76,889,000 93

15. 2015 2014 1 1 1,141,481 926,897 84,484 210,725 (9,952) / (86,488) 91,765 (138,091) (87,906) 12 31 991,434 1,141,481 4 6(b) 16. 2015 2014 1 1 549,113 539,502 16,594 138,326 (12,585) (6,715) (91,174) (66,480) (37,541) 12 31 479,927 549,113 4 6(b) 94

17. 2014 1 1 402,724 266,934 55,362 640,781 148,544 127,307 1,641,652 29,998 78,966 12,278 10,855 9,975 142,072 3,046 305 (60,114) 36,052 5,615 15,096 / (214) (2,159) (2,317) (4,260) (8,950) (24,503) (24,710) (6,406) (38,586) (6,472) (5,632) (106,309) 2015 1 1 381,053 270,368 67,808 648,208 154,282 146,746 1,668,465 33,665 112,109 42,695 7,544 1,084 197,097 58,181 1,529 (112,880) 40,083 3,312 9,775 / (33) (11,182) (1,018) (258) (12,491) (34,991) (33,003) (5,841) (46,448) (8,470) (8,652) (137,405) 2015 12 31 437,875 238,894 61,196 673,356 155,650 148,695 1,715,666 61,196 673,356 155,650 148,695 1,038,897 437,875 238,894 676,769 437,875 238,894 61,196 673,356 155,650 148,695 1,715,666 95

17. 2014 1 1 7,738 284,277 118,374 53,804 464,193 10,059 63,862 11,600 6,511 92,032 / (1,224) (2,487) (3,711) (254) (16,115) (2,952) (941) (20,262) 2015 1 1 17,543 330,800 124,535 59,374 532,252 10,873 59,519 10,795 7,323 88,510 / (9,831) (13) (214) (10,058) (1,471) (16,332) (5,859) (1,157) (24,819) 2015 12 31 26,945 364,156 129,458 65,326 585,885 2015 12 31 410,930 238,894 61,196 309,200 26,192 83,369 1,129,781 2014 12 31 363,510 270,368 67,808 317,408 29,747 87,372 1,136,213 96

17. 2015 2014 104,039 107,269 306,891 256,241 410,930 363,510 4 6(b) 384,693,000 2014 332,598,000 2047 6 27 1,557,000 2014 1,182,000 1,431,000 2014 1,211,000 97

18. 2014 1 1 465,106 173 3,077,452 126,129 418,044 188,395 9,176 4,284,475 5,603 5,603 / (1,353) (1,353) (21,519) (14) (125,555) (10,691) (19,015) (16,594) (731) (194,119) 2015 1 1 443,587 159 2,951,897 115,438 399,029 176,051 8,445 4,094,606 45,397 1,909 47,306 / (9,355) (9,355) (37,913) (19) (159,120) (16,891) (25,599) (22,030) (1,188) (262,760) 2015 12 31 405,674 140 2,792,777 98,547 373,430 190,063 9,166 3,869,797 2014 1 1 572 142 271,949 4,014 5,151 281,828 42,449 1,822 44,271 (3,356) (3,356) (49) (12) (12,382) (658) (596) (13,697) 2015 1 1 523 130 302,016 6,377 309,046 37,458 1,223 38,681 5,490 5,490 (87) (15) (17,455) (226) (918) (18,701) 2015 12 31 436 115 322,019 5,264 6,682 334,516 2015 12 31 405,238 25 2,792,777 98,547 51,411 184,799 2,484 3,535,281 2014 12 31 443,064 29 2,951,897 115,438 97,013 176,051 2,068 3,785,560 98

18. 2015 12 31 2015 2014 2015 2014 2,475,323 2,597,308 57,320 68,763 317,454 354,589 41,227 46,675 2,792,777 2,951,897 98,547 115,438 2015 12 31 5-10 10.5% 12.0% / 2015 12 31 5,490,000 (2014: 3,356,000 99

19. 2015 2014 387,131 387,131 43,805 37,286 (127,762) (88,258) 303,174 336,159 48,221 57,064 41,702 41,405 20. 2015 2014 44,707 156,815 150,016 158,000 194,723 314,815 100

21. 2015 2014 25,041 54,540 22. 2015 2014 3,338 5,207 (2,707) (4,479) 101

23. 2015 2014 394,600 371,542 279,652 270,030 249,130 329,577 923,382 971,149 3,177,462,000 (2014 3,213,721,000 24. 2015 2014 991,898 868,804 (30,532) (27,864) 961,366 840,940 155,907 144,290 1,117,273 985,230 0 90 2015 2014 0 90 888,405 761,876 90 72,961 79,064 961,366 840,940 102

24. 2015 2014 733,259 396,988 90 218,606 435,119 90 9,501 8,833 228,107 443,952 961,366 840,940 2015 2014 1 1 27,864 31,080 6,708 10,896 (108) (1,149) (1,966) (11,450) (1,966) (1,513) 12 31 30,532 27,864 103

25. 2015 2014 840,751 979,200 27 (20,349) (22,439) 820,402 956,761 0.39% (2014 1.04%) 26. 2015 2014 305,904 341,545 605,054 604,746 910,958 946,291 2015 2014 0 90 290,082 328,548 90 15,822 12,997 305,904 341,545 6,749,000 2014 2,493,000 104

27. 2015 2014 1 1,411,515 106,190 1 2 1,403,000 1,468,858 2 5 1,403,000 2,814,515 2,978,048 20,349 22,439 2,834,864 3,000,487 585,864 645,297 2,249,000 2,355,190 2,834,864 3,000,487 1,431,864 128,629 1,403,000 2,871,858 2015 2014 379,034 416,440 135,781 155,718 106,190 1,235,000 1,235,000 1,064,700 1,064,700 2,814,515 2,978,048 50,400,000 2014 57,060,000 6.1% 2014 6.1% 2016 4 2.55% 2014 2.94% 10% 2014 10% 105

28. 2015 2014 2015 2014 1 500 398 425 346 2 5 1,190 891 1,092 847 1,690 1,289 1,517 1,193 (173) (96) 1,517 1,193 1,517 1,193 425 346 1,092 847 3 5 29. 2015 2014 1 2 1,356,000 2 5 1,356,000 1,356,000 1,356,000 1,356,000 1,356,000 1.75 % 2.0 % 2014 1.75% 2.0% 106

30. / 2014 1 1 16,951 418,285 (321,151) (102,964) 11,121 / (2,341) 37,678 (46,837) 23,830 12,330 244 (1,800) 105 (4,573) (6,024) 2015 1 1 14,854 454,163 (367,883) (83,707) 17,427 / (11,130) 49,873 (24,216) (16,296) (1,769) (324) (2,169) 1,137 (4,710) (6,066) 2015 12 31 3,400 501,867 (390,962) (104,713) 9,592 2015 2014 52,889 51,194 (43,297) (33,767) 9,592 17,427 3,456,757,000 20143,262,953,000 1,009,521,000 2014 950,486,000 2,447,236,000 2014 2,312,467,000 107

30. 2015 2014 1 5 5,063 5,096 5 1,258,581 1,158,339 2,193,113 2,099,518 3,456,757 3,262,953 31. 0.10 15,000,000 1,500,000 2014 1 1 2014 12 31 2015 12 31 9,611,073 961,107 32. 2002 6 26 10% 1% 108

32. 2014 2015 12 31 2014 1 1 2014 12 31 2014 12 31 * 2014 19/1/2004 3,475,408 (3,475,408) 19/1/2005 18/1/2014 1.568 * 2006 5 (i) 35% (ii) 70% (iii) 100% 33. 585,864,000 2014 645,297,000 2015 12 31 1,113,508,000 2014 1,365,716,000 109

34. 1 19 2015 2014 1 58,568 55,276 2 5 172,779 156,501 5 44,588 54,141 1 111,383 146,619 2 5 455,429 546,896 5 366,390 479,892 35. 2015 2014 25,851 48,248 34,770 36. 5% 10% 3% 10% 42,639,000 2014 43,038,000 496,000 2014 751,000 110

37. (a) 2015 12 31 2015 2014 75 75 75 75 3,750 3,825 3,575 75 2,000 2,075 1,875 75 8,215 2,016 806 11,112 10,491 75 5,186 1,418 502 7,181 6,756 Peter Peace Tulloch 75 75 75 180 180 180 * 57 57 155 * 109 109 180 180 180 976 13,401 9,184 1,308 24,869 23,362 * 2015 5 15 2015 3 24 2015 5 15 75,000 2014 75,000 80,000 2014 80,000 25,000 2014 25,000 2015 12 31 / 111

37. (b) 2 2014 2 (a) 3 2014 3 2015 2014 11,296 17,088 5,024 4,001 731 657 17,051 21,746 2015 2014 5,000,001 5,500,000 1 5,500,001 6,000,000 1 1 6,000,001 6,500,000 1 6,500,001 7,000,000 1 9,000,001 9,500,000 1 3 3 / 112

38. 2013 12 19 Gotak Investment Limited Gotak AquaTower Pty Ltd AquaTower 51% 49% Gotak AquaTower Gotak 2014 6 AquaTower 636 55,744 983 1,476 10,554 (7,465) (1,073) 60,855 (33,084) 27,771 728 1,712 30,211 30,211 (10,554) 19,657 113

39. 8 (a) 2015 2014 2015 2014 2015 2014 2015 2014 2015 2014 2,098,857 2,216,803 2,810,296 2,730,524 10,156 6,716 4,919,309 4,954,043 242,673 323,394 440,593 386,557 45,043 24,752 728,309 734,703 (183,125) (190,823) (98,853) (113,184) (104,889) (109,566) 341,442 321,130 (72,778) (48,378) 268,664 272,752 (7,986) (9,781) (30,695) (34,490) (38,681) (44,271) (47,200) (48,069) (34,010) (36,604) (7,300) (7,359) (88,510) (92,032) / 55 872 (6,655) (10,619) (6,600) (9,747) / (86,488) 91,765 (86,488) 91,765 (6,715) (91,174) (6,715) (91,174) / (5,490) 3,356 (5,490) 3,356 18,481 18,481 (10,528) (10,108) (6,284) (10,108) (16,812) 1,712 1,712 (12,361) (12,361) 114

39. (b) i ii 2015 2014 2015 2014 3,070,320 3,064,216 3,683,930 4,054,642 1,838,833 1,883,111 2,755,667 2,893,884 4,909,153 4,947,327 6,439,597 6,948,526 i. ii. 40. (i) (ii) (iii) (iv) 26,596,000 2014 21,402,000 Hutchison International Limited HIL HIL Leknarf Associates LLC Leknarf Leknarf Vitaquest International Holdings LLC Leknarf 20,742,000 2014 17,598,000 Challenger Management Services Limited CMSL CMSL Belvino Investments Trust 10,720,000 2014 12,486,000 Cheetham Salt Limited 94,005,000 2014 111,647,000 13,117,000 2014 18,559,000 115

41. 2015 2014 2,523,848 2,523,848 6,303 3,730 2,954,482 2,954,482 61 65 2,960,846 2,958,277 (2,782) (2,226) (851,495) (745,253) (854,277) (747,479) 2,106,569 2,210,798 4,630,417 4,734,646 31 961,107 961,107 3,669,310 3,773,539 4,630,417 4,734,646 116

41. 2015 2014 1 1 3,773,539 3,867,360 (27,341) (26,543) (76,888) (67,278) 12 31 3,669,310 3,773,539 42. 51 124 2016 3 14 117

/ * 2015 2014 Accensi Pty Ltd 100 100 100 Amgrow Pty Ltd 1 100 100 Ample Castle Limited 1 100 100 ATR Packing Services Pty Ltd 100 100 ATR Property Investments Pty Ltd 100 100 100 Avandia Holdings Limited 1 100 100 Barmac Pty Ltd 7,802 100 100 Belvino Investments Pty Limited 1,000 72.30 72.30 @ Belvino Investments Trust 72.26 72.26 Biocycle Resources Limited 1 100 100 118

/ * 2015 2014 Bofanti Limited 1 100 100 Cattleya Investment Limited 1 100 100 Cheetham Salt Limited 150,405,540 100 100 2 100 100 1 100 100 10,000,000 100 100 Cupito Limited 1 100 100 Dimac Limited 1 100 100 Dunvar Investments Pty Ltd 100 100 100 Equipment Solutions Pty Ltd 100 100 100 Fertico Pty Limited 4,000,100 100 100 Globe Australia Pty Ltd 9 100 100 Growam Investments Pty Limited 10 100 100 Joyful World Global Limited 1 100 100 Lincore Limited 1 100 100 119

/ * 2015 2014 Lipa Pharmaceuticals Ltd 17,943,472.62 100 100 Marigold Investments Limited 1 100 100 # 4,050,000 * 100 100 # 300,000 * 100 100 NutriSmart Australia Pty Ltd 1 100 100 Optigen Ingredients Pty Ltd 200 100 100 Panform Limited 1 100 100 Polynoma LLC 88.60 86.67 Quest Pharmaceuticals Pty Ltd 100 100 100 QWIL Investments (NZ) Pty Limited 1 100 100 120

/ * 2015 2014 QWIL Investments Pty Ltd 100 100 100 Renascence Therapeutics Limited 100 71 71 Santé Naturelle A.G. Ltée 4,716,310 100 100 Smart Court Investments Limited 1 100 100 Turrence Limited 1 100 100 UTR Investments Pty Limited 100 100 100 2 100 100 Vitaquest International Holdings LLC 94.24 94.24 Wealth Target Development Inc. 1 100 100 Wex Pharmaceuticals Inc. 107,520,175 100 100 121

Ample Castle Limited Avandia Holdings Limited Biocycle Resources Limited Bofanti Limited Cattleya Investment Limited Cupito Limited Dimac Limited Joyful World Global Limited Lincore Limited Panform Limited Smart Court Investments Limited Turrence Limited Wealth Target Development Inc. @ Belvino Investments Trust 237,510,328 171,617,773 # Polynoma LLC Vitaquest International Holdings LLC88.60% 94.24% 122

2015 2014 Cerebos Skellerup Limited 49 49 Dominion Salt Ltd 50 50 Dominion Salt (N.I.) Limited 50 50 Salpak Pty Ltd 49 49 Western Salt Refinery Pty Ltd 50 50 123

Balranald Vineyard Balranald, New South Wales Bussorah Vineyard Padthaway, South Australia Cocoparra and Woods Vineyard Griffith, New South Wales Dalmeny Vineyard Padthaway, South Australia Del Rios Vineyard Kenley, Victoria Dunvar Vineyard Darlington Point, New South Wales Hanwood Vineyard Hanwood, New South Wales Lionels Vineyard Kaloorup, Western Australia Miamba Vineyard Lyndoch, South Australia Old Land Vineyard Anniebrook, Western Australia Qualco East Vineyard Qualco, South Australia Qualco West Vineyard Qualco, South Australia Rowe Road Vineyard Witchcliffe, Western Australia Schuberts Vineyard Lobethal, South Australia Sirens Vineyard Forest Grove, Western Australia Station & Kirkgate Vineyard Coonwarra, South Australia Stephendale Vineyard Yenda, New South Wales White Road Vineyard Tharbogang, New South Wales Whitton Vineyard Whitton, New South Wales Claim Vineyard Bendigo, Central Otago Crownthorpe Vineyard Matapiro, Hawkes Bay Dashwood Vineyard Dashwood, Marlborough Deans Vineyard Broomfield, Waipara Home Vineyard Amberley, Waipara Mound Vineyard Amberley, Waipara Northbank Vineyard Onamalutu, Marlborough Rarangi Vineyard Rarangi, Marlborough Woolshed Vineyard Renwick, Marlborough 124

A.5.1 A.5.4 A.6.7 I. C/ E A. A.1 A.1.1 C 4/4 4/4 4/4 4/4 4/4 Peter Peace Tulloch 4/4 4/4 4/4 * 3/3 ** 2/2 * ** 125

C/ E A.1.2 C A.1.3 C C A.1.4 C / / / A.1.5 A.1.6 A.1.7 C C C C C C / 126

C/ E A.1.8 C A.2 A.2.1 C C A.2.2 C 2/2 Peter Peace Tulloch 2/2 2/2 2/2 * 2/2 ** 1/1 * ** A.2.3 C / 127

C/ E A.2.4 C C C A.2.5 C A.2.6 C C A.2.3 A.2.4 A.2.7 C A.2.2 128

C/ E A.2.8 A.2.9 C (i) (ii) (iii) (iv) (v) (vi) (vii) C A.3 A.3.1 C 166 28 31 129

C/ E A.3.2 C A.4 A.4.1 C A.4.2 C C 130

C/ E A.4.3 A.5 C C 3.13 3.13 A.3 A.4 A.5.1 A.5.4 E 131

C/ E A.5.1 A.5.4 (a) (b) (c) (d) 132

C/ E A.5.5 C A.4.3 / A.5.6 C 1. 2. / 3. 133

C/ E A.6 A.6.1 A.6.2 C C C C C 134

C/ E A.6.3 A.6.4 C A.1.1 C XIVA 135

C/ E A.6.5 C / (1) (2) / / / / / (3) / / / 136

C/ E A.6.5 (1) (2) (3) (1) (3) (1) (3) (1) (2) (1) (2) Peter Peace Tulloch (1) (2) (1) (2) (1) (2) * (1) (2) (3) * A.6.6 A.6.7 C E A.1.1 A.2.2 B.1.2 C.3.1 E.1.2 137

C/ E A.6.8 C A.6.7 A.7 A.7.1 A.7.2 A.7.3 C C C C C C / / / / A.7.1 A.7.2 138

C/ E B. B.1 B.1.1 / C / 139

C/ E B.1.2 C 2/2 2/2 2/2 1. 2. 3. 4. 5. 140

C/ E B.1.3 B.1.4 B.1.5 C C C 37 C. C.1 C.1.1 C.1.2 C C C.1.2 141

C/ E C.1.3 C C C C.1.3 49 50 C.1.4 C.1.5 C C 142

C/ E C.2 C.2.1 C C 143

C/ E C.2.2 C C.3.3 C.3 C.3.1 C C * 1/1 2/2 2/2 ** 1/1 * ** 1. 2. 3. 4. 5. 6. 7. 8. 9. / 144

C/ E C.3.1 C.3.2 C.3.3 C C 145

C/ E C.3.4 C.3.5 C.3.6 C 11,923,000 3,214,000 2,624,000 590,000 C 146

C/ E C.3.7 C C D. D.1 D.1.1 C 160 147

C/ E D.1.2 D.1.3 D.1.4 C C 160 C D.2 D.2.1 D.2.2 C C.3.3 B.1.3 C 148

C/ E D.3 D.3.1 D.3.2 D.3.1 C 1. 2. 3. 4. 5. C D.3.1 149

C/ E E. E.1 E.1.1 C E.1.2 C C C 1/1 1/1 1/1 1/1 1/1 Peter Peace Tulloch 0/1 1/1 1/1 * 1/1 ** 1/1 * ** 150

C/ E E.1.3 E.1.4 C C 1. 2. 72 3. 120 4. 151

C/ E E.1.4 5. 167 6. 7. 2 7 E.2 E.2.1 C 152

C/ E F. / F.1.1 F.1.2 F.1.3 F.1.4 / C C C C 153

II. C/ E A. A.1 A.1 A.2 A.2 A.3 A.3 A.4 A.4 A.5 A.3 A.4 A.5 A.6 A.6 A.7 A.7 154

C/ E B. B.1 B.1.6 B.1.7 B.1.8 C 37 C 37 B.1.9 E 155

C/ E C. C.1 C.1.6 C.1.7 E C.1.6 156

C/ E C.2 C.2.3 C C C C C 157

C/ E C.2.4 C.2.1 C C C C C C.2.5 C.2.6 C C.2 C.3 C.3.8 C C.3.7 158

C/ E D. D.1 D.1 D.2 D.2 D.3 D.3 E. E.1 E.1 E.2 E.2 F. / F 159

* Peter Peace Tulloch * * 160

161

/ 162

(a) (b) (c) (d) (e) Challenger Wine Trust 163

164

/ / (a) (b) 165

Peter Peace Tulloch ( 主 席 ) ( 主 席 ) 主 席 總 裁 及 行 政 總 監 高 級 副 總 裁 及 投 資 總 監 副 總 裁 及 營 運 總 監 副 總 裁 及 科 學 總 監 非 執 行 董 事 獨 立 非 執 行 董 事 獨 立 非 執 行 董 事 獨 立 非 執 行 董 事 P.O. Box 309GT Ugland House South Church Street Grand Cayman Cayman Islands 2 2 7 Royal Bank of Canada Trust Company (Cayman) Limited 4th Floor, Royal Bank House 24 Shedden Road, George Town Grand Cayman KY1-1110 Cayman Islands 166

183 17 1712-1716 0775 775 HK 0775.HK www.ck-lifesciences.com ( 包 括 首 尾 兩 天 在 內 ) 167

183 17M cklife.ecom@computershare.com.hk www.ck-lifesciences.com cklife.ecom@computershare.com.hk cklife.ecom@computershare.com.hk cklife.ecom@computershare.com.hk / 168

長江生命科技簡介 長江生命科技集團有限公司於香港聯合交易所有限公司 上市 本著提升人類生活質素之使命 長江生命科技從事 健康及農業相關產品的研發 商品化 推廣及銷售業務 開發之產品範疇包括人類健康及環境生態兩方面 部分 發明已獲得美國專利及商標註冊處頒發專利 長江生命 科技為長江和記實業集團成員

2 (852) 2126 1212 (852) 2126 1211 www.ck-lifesciences.com